Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dianthus Therapeutics (DNTH) EPS (Weighted Average and Diluted): 2022-2024

Historic EPS (Weighted Average and Diluted) for Dianthus Therapeutics (DNTH) over the last 3 years, with Dec 2024 value amounting to -$2.55.

  • Dianthus Therapeutics' EPS (Weighted Average and Diluted) fell 31.08% to -$0.97 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.49, marking a year-over-year decrease of 148.74%. This contributed to the annual value of -$2.55 for FY2024, which is 69.82% up from last year.
  • Per Dianthus Therapeutics' latest filing, its EPS (Weighted Average and Diluted) stood at -$2.55 for FY2024, which was up 69.82% from -$8.45 recorded in FY2023.
  • Dianthus Therapeutics' 5-year EPS (Weighted Average and Diluted) high stood at -$2.55 for FY2024, and its period low was -$32.57 during FY2022.
  • In the last 3 years, Dianthus Therapeutics' EPS (Weighted Average and Diluted) had a median value of -$8.45 in 2023 and averaged -$14.52.
  • Data for Dianthus Therapeutics' EPS (Weighted Average and Diluted) shows a peak YoY spiked of 74.06% (in 2023) over the last 5 years.
  • Dianthus Therapeutics' EPS (Weighted Average and Diluted) (Yearly) stood at -$32.57 in 2022, then soared by 74.06% to -$8.45 in 2023, then soared by 69.82% to -$2.55 in 2024.